Amanote Research
Register
Sign In
680. Gene Therapy of Chondroitin Sulfate-Coated Ternary GM-CSF Plasmid Complex for Ovarian Cancer
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)36484-x
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2012
Authors
Unknown
Publisher
Elsevier BV
Related search
Crystallization and Preliminary X-Ray Diffraction Analysis of the Ternary Human GM-CSF Receptor Complex
Acta Crystallographica Section F Structural Biology and Crystallization Communications
Anti‐GM‐CSF Therapy in Psoriasis
British Journal of Dermatology
Dermatology
Medicine
GM-CSF Therapy in Pulmonary Alveolar Proteinosis
Thorax
Pulmonary
Respiratory Medicine
Novel GM-CSF-based Vaccines: One Small Step in GM-CSF Gene Optimization, One Giant Leap for Human Vaccines
Human Vaccines and Immunotherapeutics
Medicine
Allergy
Immunology
Pharmacology
Gm-CSF
Autoimmune Pulmonary Alveolar Proteinosis and GM-CSF Inhalation Therapy
Folia Pharmacologica Japonica
Pharmacology
Viral Gene Therapy Active in Ovarian Cancer
Nature Reviews Clinical Oncology
Oncology
Histochemical Differentiation Between Chondroitin 4-Sulfate and Chondroitin 6-Sulfate.
Kurume Medical Journal
Medicine
Chondroitin Synthases I, II, III and Chondroitin Sulfate Glucuronyltransferase Expression in Colorectal Cancer
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine